|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Aug 11, 2020 |
Title |
Identification of Drugs Blocking SARS-CoV-2 Infection using hPSC-derived Lung and Colonic Organoids |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
The SARS-CoV-2 has already caused over twelve million COVID-19 cases and half a million deaths worldwide. There is an urgent need to create novel models using human disease-relevant cells to study SARS-CoV-2 biology and to facilitate drug screening. As SARS-CoV-2 primarily infects the respiratory tract, we developed a lung organoid model using human pluripotent stem cells (hPSC-LOs) that could be adapted for drug screening. The hPSC-LOs, particularly alveolar type II-like cells, express the viral entry receptor ACE2, are permissive to SARS-CoV-2 infection, and showed robust induction of chemokines and cytokines upon SARS-CoV-2 infection, similar to what is seen in COVID-19 patients. Nearly 25% of these patients have gastrointestinal manifestations, which are associated with worse COVID-19 outcomes1. We therefore also generated complementary hPSC-derived colonic organoids (hPSC-COs) to explore the response of colonic cells to SARS-CoV-2 infection. We found that multiple colonic cell types, especially enterocytes, express ACE2 and are permissive to SARS-CoV-2 infection. Using hPSC-LOs, we performed a high throughput screen of FDA-approved drugs and identified entry inhibitors of SARS-CoV-2, including imatinib, mycophenolic acid (MPA), and quinacrine dihydrochloride (QNHC). Pre- or post-infection treatment at physiologically relevant levels of these drugs significantly inhibited SARS-CoV-2 infection of both hPSC-LOs and hPSC-COs. Together, these data demonstrate that hPSC-LOs and hPSC-COs infected by SARS-CoV-2 can serve as disease models to study SARS-CoV-2 infection and provide a valuable resource for drug screening to identify candidate COVID-19 therapeutics.
|
|
|
Overall design |
COVID-19 lung biopsy and SARS-CoV-2 infected lung organoids
|
|
|
Contributor(s) |
Han Y, Yang L, Chen S, Nilsson-Payant BE, Bram Y, Schwartz RE, tenOever BR |
Citation(s) |
33116299 |
|
Submission date |
Jul 27, 2020 |
Last update date |
Jan 05, 2022 |
Contact name |
Shuibing Chen |
E-mail(s) |
shuibing.chen@gmail.com
|
Phone |
2127465431
|
Organization name |
Weill Cornell Medical College
|
Department |
Surgery
|
Street address |
A 827B, 1300 York Ave
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (18)
|
GSM4697982 |
Healthy Lung autopsy [Healthy-lung] |
GSM4697983 |
Healthy Lung autopsy_1 [HealthyLungBiopsy_1] |
GSM4697984 |
Healthy Lung autopsy_2 [HealthyLungBiopsy_2] |
GSM4697985 |
COVID_19 lung autopsy_1 [COVI19-Lung_59L-H1] |
GSM4697986 |
COVID_19 lung autopsy_2 [COVI19-Lung_62L-H2] |
GSM4697987 |
COVID_19 lung autopsy_3 [COVI19-Lung_64L-H3] |
GSM4697988 |
hPSC_Lung organoid_mock_1 [2A] |
GSM4697989 |
hPSC_Lung organoid_mock_2 [2B] |
GSM4697990 |
hPSC_Lung organoid_mock_3 [2C] |
GSM4697991 |
hPSC_Lung organoid_SARS-CoV-2_1 [2D] |
GSM4697992 |
hPSC_Lung organoid_SARS-CoV-2_2 [2E] |
GSM4697993 |
hPSC_Lung organoid_SARS-CoV-2_3 [2F] |
GSM4718728 |
hPSC_Lung organoid_SARS-CoV-2_DMSO_1 [LungOrganoid-DMSO-1] |
GSM4718729 |
hPSC_Lung organoid_SARS-CoV-2_DMSO_2 [LungOrganoid-DMSO-2] |
GSM4718730 |
hPSC_Lung organoid_SARS-CoV-2_DMSO_3 [LungOrganoid-DMSO-3] |
GSM4718731 |
hPSC_Lung organoid_SARS-CoV-2_imatinib_1 [LungOrganoid-10uM-Imatinib-1] |
GSM4718732 |
hPSC_Lung organoid_SARS-CoV-2_imatinib_2 [LungOrganoid-10uM-Imatinib-2] |
GSM4718733 |
hPSC_Lung organoid_SARS-CoV-2_imatinib_3 [LungOrganoid-10uM-Imatinib-3] |
|
Relations |
BioProject |
PRJNA649019 |
SRA |
SRP273808 |
Supplementary file |
Size |
Download |
File type/resource |
GSE155241_Processed_gene_expression.2.xlsx |
1.9 Mb |
(ftp)(http) |
XLSX |
GSE155241_Processed_gene_expression.xlsx |
2.9 Mb |
(ftp)(http) |
XLSX |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|